Get 40% Off
🚨 Markets Are Down. Unlock Undervalued StocksFind Stocks Now

Australia helps Sri Lanka to control dengue fever after 250 die

Published 20/07/2017, 04:48 am
Updated 20/07/2017, 04:50 am
© Reuters.  Australia helps Sri Lanka to control dengue fever after 250 die

COLOMBO, July 19 (Reuters) - Australia announced programmes on Wednesday to help control dengue fever in Sri Lanka, where the mosquito-borne disease killed more around 250 people in the first half of this year.

A short-term programme through the World Health Organisation

will try to reduce the transmission of the dengue virus, aiming for a reduction of more than 50 percent over a period of four to six weeks.

A longer-term programme will use Wolbachia bacteria, a microbe that prevents the dengue virus from replicating inside the mosquitoes that carry it, to halt its transmission to people. Similar campaigns are under way in Brazil and Colombia to fight the spread of dengue and Zika viruses programmes were announced by Julie Bishop, the Australian minister of foreign affairs, during a two-day visit to Colombo.

The Sri Lankan government is struggling to control the dengue virus, which causes flu-like symptoms and can develop into the deadly hemorrhagic dengue fever. Around 100,000 people have been infected, and the number of infected has accelerated since floods in mid-May. Some hospitals have run out of beds.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.